お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
959872

心房細動の世界市場 - 2027年までの予測:COVID-19の影響、治療タイプ (非薬理学的・薬理学的)・エンドユーザー (病院・ASC・心臓カテーテル室)・地域別の分析

Atrial Fibrillation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type (Non-pharmacological, Pharmacological); End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories); and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 150 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.20円
心房細動の世界市場 - 2027年までの予測:COVID-19の影響、治療タイプ (非薬理学的・薬理学的)・エンドユーザー (病院・ASC・心臓カテーテル室)・地域別の分析
出版日: 2020年08月28日
発行: The Insight Partners
ページ情報: 英文 150 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における心房細動の市場規模は、2019年に64億4608万米ドルとなり、2027年までに180億8596万米ドルへ達すると予測され、2020年から2027年にかけて14.0%のCAGRで成長すると見込まれています。

当レポートでは、世界の心房細動市場について調査分析し、各セグメント・地域別の市場分析と予測、市場発展への影響要因、競合情勢、主要企業のプロファイルなどについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 心房細動:要点

第3章 調査手法

第4章 心房細動:市場情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 心房細動市場:主な業界力学

  • 市場成長促進要因
  • 市場成長抑制要因
  • 市場機会
  • 将来の動向
  • 影響分析

第6章 心房細動:世界の分析

  • 世界市場の収益予測・分析
  • 世界市場の予測・分析:地域別
  • 主要企業の市場シェア

第7章 心房細動市場の分析:治療タイプ別

  • 概要
  • 非薬理学的
  • 薬理学的

第8章 心房細動市場の分析:エンドユーザー別

  • 概要
  • 市場:エンドユーザー別
  • 病院
  • 通院外科診療所 (ASC)
  • 心臓カテーテル室

第9章 心房細動市場:地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第10章 心房細動市場:業界情勢

  • 概要

第14章 主要企業プロファイル

  • Boston Scientific Corporation
  • Medtronic
  • AtriCure, Inc.
  • Biosense Webster, Inc.
  • BOEHRINGER INGELHEIM GMBH
  • CardioFocus.
  • Abbott
  • Sanofi
  • Bristol-Myers Squibb Company
  • Biotronik, Inc.

第12章 付録

  • The Insight Partners について
  • 用語集
図表

List Of Tables

  • Table 1. Prevalence of Atrial Fibrillation In APAC Region (By Country)
  • Table 2. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
  • Table 3. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 4. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 5. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • Table 6. US Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 7. US Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 8. US Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 9. US Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 10. Canada Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 11. Canada Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 12. Canada Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 13. Canada Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 14. Mexico Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 15. Mexico Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 16. Mexico Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 17. Mexico Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 18. Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
  • Table 19. Europe Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 20. Europe Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 21. Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • Table 22. Germany Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 23. Germany Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 24. Germany Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 25. Germany Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 26. UK Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 27. UK Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 28. UK Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 29. UK Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 30. France Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 31. France Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 32. France Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 33. France Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 34. Spain Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 35. Spain Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 36. Spain Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 37. Spain Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 38. Italy Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 39. Italy Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 40. Italy Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 41. Italy Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 42. Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
  • Table 43. Asia Pacific Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 44. Asia Pacific Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 45. Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • Table 46. China Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 47. China Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 48. China Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 49. China Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 50. Japan Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 51. Japan Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 52. Japan Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 53. Japan Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 54. India Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 55. India Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 56. India Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 57. India Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 58. South Korea Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 59. South Korea Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 60. South Korea Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 61. South Korea Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 62. Australia Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 63. Australia Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 64. Australia Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 65. Australia Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 66. Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
  • Table 67. Middle East & Africa Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 68. Middle East & Africa Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 69. Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • Table 70. Saudi Arabia Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 71. Saudi Arabia Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 72. Saudi Arabia Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 73. Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 74. UAE Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 75. UAE Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 76. UAE Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 77. UAE Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 78. South Africa Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 79. South Africa Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 80. South Africa Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 81. South Africa Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 82. South and Central America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 83. South and Central America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
  • Table 84. South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • Table 85. Brazil Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 86. Brazil Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 87. Brazil Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 88. Brazil Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 89. Argentina Atrial Fibrillation Market Revenue and Forecast To 2027, by Treatment Type (US$ Mn)
  • Table 90. Argentina Non-Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 91. Argentina Pharmacological Market Revenue and Forecast To 2027, by Type (US$ Mn)
  • Table 92. Argentina Atrial Fibrillation Market, Revenue and Forecast To 2027, by End User (US$ Mn)
  • Table 93. Recent Developments in THE atrial fibrillation market
  • Table 94. Glossary of Terms, Atrial Fibrillation Market

List Of Figures

  • Figure 1. Atrial Fibrillation Market Segmentation
  • Figure 2. Atrial Fibrillation Market Segmentation, By Region
  • Figure 3. Global Atrial Fibrillation Market Overview
  • Figure 4. Non-Pharmacological Segment Held Largest Share Of Treatment Type Segment In Atrial Fibrillation Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Atrial Fibrillation Market, By Geography (US$ Mn)
  • Figure 7. Global Atrial Fibrillation Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Atrial Fibrillation Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America PEST Analysis
  • Figure 14. Atrial Fibrillation Market Impact Analysis of Drivers and Restraints
  • Figure 15. Global Atrial Fibrillation Market - Revenue Forecast And Analysis - 2018- 2027
  • Figure 16. Global Atrial Fibrillation Market - By Geography Forecast And Analysis - 2019- 2027
  • Figure 17. Market Share Of Key Player In Global Atrial Fibrillation Market
  • Figure 18. Atrial Fibrillation Market, by Treatment Type, 2019 and 2027 (%)
  • Figure 19. Non-Pharmacological Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. MAZE Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Catheter Ablation Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Electric Cardioversion Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Pharmacological Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 24. Anti-Arrhythmic Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Anti-Coagulant Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Atrial Fibrillation Market, by End-User, 2019 & 2027 (%)
  • Figure 27. Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 28. Ambulatory Surgery Centres Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Cardiac Catheterization Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. North America Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
  • Figure 31. North America Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 32. North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
  • Figure 33. US Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 34. Canada Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 35. Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 36. Europe Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
  • Figure 37. Europe Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 38. Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
  • Figure 39. Germany Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 40. UK Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 41. France Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 42. Spain Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 43. Italy Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 44. Asia Pacific Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
  • Figure 45. Asia Pacific Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 46. Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
  • Figure 47. China Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 48. Japan Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 49. India Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 50. South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 51. Australia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 52. Middle East & Africa Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
  • Figure 53. Middle East & Africa Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 54. Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
  • Figure 55. Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 56. UAE Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 57. South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 58. South and Central America Atrial Fibrillation Market, Revenue by Country (2019) (US$ Mn)
  • Figure 59. South and Central America Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 60. South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
  • Figure 61. Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 62. Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
目次
Product Code: TIPRE00003531

The global Atrial Fibrillation is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027.

Driving factors of the Atrial Fibrillation market are increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. Besides, development opportunities in emerging countries is expected to have a positive effect on the growth of the market in the forecast years. However, high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years.

Atrial fibrillation is among the most commonly occurring heart condition, which causes irregular and often abnormally fast heart rates, which can lead to the possibility of a stroke. A large number of populations across the globe are unaware of the symptoms associated with atrial fibrillation and hence remain untreated. As per Eastern AHSN, across England, approximately 425,000 people are living with undiagnosed and untreated AF. Various associations across the world have been involved in undertaking awareness regarding the medical condition. For instance, Health Innovation Manchester in November 2018 raised awareness regarding Atrial Fibrillation and other innovative technologies to increase the detection of the disease as part of the Global AF Aware Week.

Other than bodies such as associations and organizations, companies in the market have also played an instrumental role in increasing the awareness regarding atrial fibrillation. For instance, Biosense Webster, a Division of Johnson & Johnson, launched two major initiatives as a part of the Global AF Aware Week, which falls between 18-24 November. As a part of the action named Get Smart About AFIB (GSAAF), the company entered into a strategic partnership with the Arrhythmia Alliance to increase knowledge of AF across the healthcare community and the general public. As awareness helps in improving the medical care needed for the treatment of atrial fibrillation, the market is expected to witness considerable growth during the forecast period.

The global Atrial Fibrillation is segmented by treatment type and end user. The atrial fibrillation market, by treatment type, is segmented into non-pharmacological and pharmacological. The non-pharmacological segment held the largest share of the market in 2019. The segment is also anticipated to register the highest CAGR in the market during the forecast period.

Based on end-user, the atrial fibrillation market is segmented into hospitals, ambulatory surgical centers and cardiac catheterization laboratories. The hospitals segment held the largest share of the market in 2019. In addition, the segment is also estimated to register the highest CAGR in the market during the forecast period.

Some of the essential primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), World Stroke Organization, Health Authority of Abu Dhabi, European Heart Network among others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the atrial fibrillation market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global atrial fibrillation market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Atrial Fibrillation Market - By Treatment Type
    • 1.3.2 Global Atrial Fibrillation Market - By End User
    • 1.3.3 Global Atrial Fibrillation Market - By Geography

2. Atrial Fibrillation Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Atrial Fibrillation- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Atrial Fibrillation Market - Key Dynamics

  • 5.1 Drivers
    • 5.1.1 Increasing Prevalence Of Atrial Fibrillation
    • 5.1.2 Rising Awareness Regarding Atrial Fibrillation
  • 5.2 Restraints
    • 5.2.1 High Cost Of Atrial Fibrillation Devices and Procedures
  • 5.3 Key Market Opportunities
    • 5.3.1 Growth Opportunities in The Developing Nations
  • 5.4 Future Trends
    • 5.4.1 Development of Novel Technologies
  • 5.5 Impact Analysis

6. Atrial Fibrillation Market - Global Analysis

  • 6.1 Global Atrial Fibrillation Market Revenue Forecast And Analysis
  • 6.2 Global Atrial Fibrillation Market, By Geography - Forecast And Analysis
  • 6.3 Market Share of Key Players
    • 6.3.1 Biosense Webster, Inc. (Johnson & Johnson)
    • 6.3.2 Medtronic

7. Atrial Fibrillation Market Analysis and Forecast - By Treatment Type

  • 7.1 Overview
  • 7.2 Atrial Fibrillation Market, by Treatment Type, 2019 and 2027 (%)
  • 7.3 Non-Pharmacological
    • 7.3.1 Overview
    • 7.3.2 Non-Pharmacological Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.3 MAZE Surgery
      • 7.3.3.1 Overview
      • 7.3.3.2 MAZE Surgery Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.4 Catheter Ablation
      • 7.3.4.1 Overview
      • 7.3.4.2 Catheter Ablation Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.5 Electric Cardioversion Market
      • 7.3.5.1 Overview
      • 7.3.5.2 Electric Cardioversion Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Pharmacological
    • 7.4.1 Overview
    • 7.4.2 Pharmacological Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.3 Anti-Arrhythmic Drugs Market
      • 7.4.3.1 Overview
      • 7.4.3.2 Anti-Arrhythmic Drugs Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.4 Anti-Coagulant Drugs Market
      • 7.4.4.1 Overview
      • 7.4.4.2 Anti-Coagulant Drugs Market Revenue and Forecast to 2027 (US$ Mn)

8. Atrial Fibrillation Market Analysis and Forecast to 2027 - End-User

  • 8.1 Overview
  • 8.2 Atrial Fibrillation Market, by End-User, 2019 & 2027 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Ambulatory Surgical Centres
    • 8.4.1 Overview
    • 8.4.2 Ambulatory Surgery Centres Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.5 Cardiac Catheterization Laboratories
    • 8.5.1 Overview
    • 8.5.2 Cardiac Catheterization Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

9. Atrial Fibrillation Market - Geographic Analysis

  • 9.1 North America Atrial Fibrillation Market, Revenue and Forecast to 2027
    • 9.1.1 Overview
    • 9.1.2 North America Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
    • 9.1.3 North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
      • 9.1.3.1 North America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.1.3.2 North America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
    • 9.1.4 North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.1.5 North America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
    • 9.1.6 United States
      • 9.1.6.1 US Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.1.6.2 US Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.1.6.2.1 US Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.1.6.2.2 US Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.1.6.3 US Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.1.7 Canada
      • 9.1.7.1 Canada Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.1.7.2 Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.1.7.2.1 Canada Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.1.7.2.2 Canada Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.1.7.3 Canada Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.1.8 Mexico
      • 9.1.8.1 Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.1.8.2 Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.1.8.2.1 Mexico Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.1.8.2.2 Mexico Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.1.8.3 Mexico Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • 9.2 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027
    • 9.2.1 Overview
    • 9.2.2 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
    • 9.2.3 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
      • 9.2.3.1 Europe Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.2.3.2 Europe Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
    • 9.2.4 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.2.5 Europe Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
    • 9.2.6 Germany
      • 9.2.6.1 Germany Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.2.6.2 Germany Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.2.6.2.1 Germany Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.2.6.2.2 Germany Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.2.6.3 Germany Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.2.7 United Kingdom
      • 9.2.7.1 UK Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.2.7.2 UK Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.2.7.2.1 UK Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.2.7.2.2 UK Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.2.7.3 UK Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.2.8 France
      • 9.2.8.1 France Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.2.8.2 France Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.2.8.2.1 France Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.2.8.2.2 France Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.2.8.3 France Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.2.9 Spain
      • 9.2.9.1 Spain Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.2.9.2 Spain Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.2.9.2.1 Spain Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.2.9.2.2 Spain Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.2.9.3 Spain Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.2.10 Italy
      • 9.2.10.1 Italy Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.2.10.2 Italy Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.2.10.2.1 Italy Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.2.10.2.2 Italy Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.2.10.3 Italy Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • 9.3 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
    • 9.3.3 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
      • 9.3.3.1 Asia Pacific Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.3.3.2 Asia Pacific Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
    • 9.3.4 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.3.5 Asia Pacific Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
    • 9.3.6 China
      • 9.3.6.1 China Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.6.2 China Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.3.6.2.1 China Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.3.6.2.2 China Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.3.6.3 China Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.3.7 Japan
      • 9.3.7.1 Japan Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.7.2 Japan Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.3.7.2.1 Japan Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.3.7.2.2 Japan Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.3.7.3 Japan Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.3.8 India
      • 9.3.8.1 India Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.8.2 India Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.3.8.2.1 India Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.3.8.2.2 India Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.3.8.3 India Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.3.9 South Korea
      • 9.3.9.1 South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.9.2 South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.3.9.2.1 South Korea Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.3.9.2.2 South Korea Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.3.9.3 South Korea Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.3.10 Australia
      • 9.3.10.1 Australia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.3.10.2 Australia Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.3.10.2.1 Australia Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.3.10.2.2 Australia Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.3.10.3 Australia Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • 9.4 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
    • 9.4.3 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type (US$ Mn)
      • 9.4.3.1 Middle East & Africa Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.4.3.2 Middle East & Africa Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
    • 9.4.4 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.4.5 Middle East & Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
    • 9.4.6 Saudi Arabia
      • 9.4.6.1 Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.4.6.2 Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.4.6.2.1 Saudi Arabia Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.4.6.2.2 Saudi Arabia Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.4.6.3 Saudi Arabia Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.4.7 UAE
      • 9.4.7.1 UAE Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.4.7.2 UAE Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.4.7.2.1 UAE Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.4.7.2.2 UAE Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.4.7.3 UAE Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.4.8 South Africa
      • 9.4.8.1 South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.4.8.2 South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.4.8.2.1 South Africa Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.4.8.2.2 South Africa Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.4.8.3 South Africa Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
  • 9.5 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027
    • 9.5.1 Overview
    • 9.5.2 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
    • 9.5.3 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
      • 9.5.3.1 South and Central America Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.5.3.2 South and Central America Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
    • 9.5.4 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.5.5 South and Central America Atrial Fibrillation Market, Revenue and Forecast to 2027, by Country (%)
    • 9.5.6 Brazil
      • 9.5.6.1 Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.5.6.2 Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.5.6.2.1 Brazil Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.5.6.2.2 Brazil Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.5.6.3 Brazil Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)
    • 9.5.7 Argentina
      • 9.5.7.1 Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027 (US$ Mn)
      • 9.5.7.2 Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027, by Treatment Type(US$ Mn)
        • 9.5.7.2.1 Argentina Non-Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
        • 9.5.7.2.2 Argentina Pharmacological Market, Revenue and Forecast to 2027, by Type (US$ Mn)
      • 9.5.7.3 Argentina Atrial Fibrillation Market, Revenue and Forecast to 2027, by End User (US$ Mn)

10. Atrial Fibrillation Market -Industry Landscape

  • 10.1 Overview
    • 10.1.1 Recent Developments by Players in Atrial Fibrillation Market

11. Atrial Fibrillation Market- Key Company Profiles

  • 11.1 Boston Scientific Corporation
    • 11.1.1 1.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Medtronic
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 AtriCure, Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Biosense Webster, Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 BOEHRINGER INGELHEIM GMBH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 CardioFocus.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Abbott
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Sanofi
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Bristol-Myers Squibb Company
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Biotronik, Inc.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.